000			02151cam a2200349 a 4500
003			EG-GiCUC
005			20250223031637.0
008			170109s2014 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.11.33.Ph.D.2014.Ra.P
100	0		_aRabab Abdelsalam Nashaa{u00B4}t Moharram
245	1	0	_aPrediction of sustained viral response in chronic HCV patients treated with pegylated interferon and ribavirin / _cRabab Abdelsalam Nashaa{u00B4}t Moharram ; Supervised Gamal Eldin Esmat Mohamed , Ashraf Omar Abdelaziz , Abdelrahman Nabawi Zekri
246	1	5	_aتوقع الاستجابة طويلة المدى لدى المرضى المصابين بفيروس"سى" المزمن مع العلاج بالانتلافيرون طويل المفعول والريبافيرين
260			_aCairo : _bRabab Abdelsalam Nashaa{u00B4}t Moharram , _c2014
300			_a126 P. : _bcharts ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
520			_aIn this study, the concept of rapid viral response (RVR) and very early viral response (VEVR) has been validated in predicting SVR in chronic HCV patients treated with pegylated interferon plus ribavirin specially regarding the PPV and the NPV, as there is limited information available regarding treating hepatitis C genotype 4.This prospective cohort study was performed on 125 out-patients with chronic HCV infection who attended to the N.H.T.M.R.I & were candidates for treatment with pegylated interferon alpha & ribavirin. Out of the 125 patients, 20 patients were withdrawn due to non-response at week
530			_aIssued also as CD
653		4	_aHCV
653		4	_aInterferon and ribavirin
653		4	_aSustained viral response
700	0		_aAbdelrahman Nabawi Zekri , _eSupervisor
700	0		_aAshraf Omar Abdelaziz , _eSupervisor
700	0		_aGamal Eldin Esmat Mohamed , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aShaima _eCataloger
942			_2ddc _cTH
999			_c59372 _d59372